Inventor · disambiguated record
Jiangtao Ren
Also filed as: REN JIANGTAO
14 granted patents·22 pending applications·24 citations·filing 2015–2025
87Inventor score
Top patents by PatentIndex Score
36 records- 0196US11203758B2Altering gene expression in modified T cells and uses thereofUNIV PENNSYLVANIA·Filed 2018·Granted Dec 21, 2021·12 cites·16 claims
- 0295US11208661B2Altering gene expression in modified T cells and uses thereofUNIV PENNSYLVANIA·Filed 2015·Granted Dec 28, 2021·8 cites·14 claims
- 0386US12344843B2Altering gene expression in cart cells and uses thereofUNIV PENNSYLVANIA·Filed 2020·Granted Jul 1, 2025·1 cites·8 claims
- 0486US12291707B2Modified immune cells having enhanced function and methods for screening the sameUNIV PENNSYLVANIA·Filed 2024·Granted May 6, 2025·0 cites·5 claims
- 0586US2024279665A1Altering Gene Expression in CART Cells and Uses ThereofUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 0680US12029760B2Compositions and methods for gene editing in T cells using CRISPR/Cpf1UNIV PENNSYLVANIA·Filed 2018·Granted Jul 9, 2024·1 cites·12 claims
- 0778US11920130B2Modified immune cells having enhanced function and methods for screening for sameUNIV PENNSYLVANIA·Filed 2022·Granted Mar 5, 2024·0 cites·19 claims
- 0877US11896620B2Engineered immune cell and use thereofNANJING BIOHENG BIOTECH CO LTD·Filed 2021·Granted Feb 13, 2024·1 cites·22 claims
- 0976US2025243481A1Modified immune cells having enhanced function and methods for screening the sameUNIV PENNSYLVANIA·Filed 2025·Application pending·0 cites
- 1075US2024316107A1Compositions and Methods for Gene Editing in T Cells Using CRISPR/Cpf1UNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 1171US11447769B2Modified immune cells having enhanced function and methods for screening for sameUNIV PENNSYLVANIA·Filed 2019·Granted Sep 20, 2022·0 cites·6 claims
- 1259US10917561B2Image processing in an unmanned autonomous vehicleQUALCOMM INC·Filed 2016·Granted Feb 9, 2021·1 cites·19 claims
- 1356US2025354154A1Engineered immune cell with cd7 gene knock-out and use thereofNANJING BIOHENG BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 1452US2023399398A1Cd7-targeting humanized antibody and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1552US2023390336A1Chimeric antigen receptor targeting cd7 and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1651US11720100B2Systems and methods for utilizing semantic information for navigation of a robotic deviceQUALCOMM INC·Filed 2018·Granted Aug 8, 2023·0 cites·35 claims
- 1751US2024018236A1Cd19-targeting humanized antibody and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1851US2024052029A1Ror1-targeting antibody and use thereofBIOHENG THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1951US2025297259A1Engineered immune cell with ciita gene knock-out and use thereofNANJING BIOHENG BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 2050US11340615B2Concurrent relocation and reinitialization of VSLAMQUALCOMM INC·Filed 2017·Granted May 24, 2022·0 cites·34 claims
- 2150US2024082306A1Novel chimeric antigen receptor and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2250US2024043532A1Nkg2a-targeting antibody and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2349US11998567B2Engineered chimeric guide RNA and uses thereofNANJING BIOHENG BIOTECH CO LTD·Filed 2020·Granted Jun 4, 2024·0 cites·4 claims
- 2448US2024009308A1Chimeric antigen receptor comprising novel co-stimulatory domain and use thereofNANJING BIOHENG BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 2548US2024009311A1Engineered immune cell and use thereofNANJING BIOHENG BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 2648US2024018251A1Bcma-targeting single-domain antibody and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2748US2023270858A1Novel co-stimulatory domain and use thereofNANJING BIOHENG BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 2847US2024338035A1Selecting A Frontier Goal For Autonomous Map Building Within A SpaceQUALCOMM INC·Filed 2021·Application pending·0 cites
- 2947US2023242661A1Engineered immune cell expressing nk inhibitory molecule and use thereofNANJING BIOHENG BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 3046US2023248768A1Engineered immune cell for allotransplantationNANJING BIOHENG BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 3146US2023242877A1Immune cell comprising chimeric antigen receptor and use thereofNANJING BIOHENG BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 3245US11080890B2Image sensor initialization in a robotic vehicleQUALCOMM INC·Filed 2017·Granted Aug 3, 2021·0 cites·30 claims
- 3343US10873702B2Adaptive motion filtering in an unmanned autonomous vehicleQUALCOMM INC·Filed 2017·Granted Dec 22, 2020·0 cites·19 claims
- 3441US2020377878A1Modified t cells and uses thereofNANJING BIOHENG BIOTECH CO LTD·Filed 2020·Application pending·0 cites
- 3539US2020117210A1Auto-Exploration Control of a Robotic VehicleQUALCOMM INC·Filed 2017·Application pending·0 cites
- 3637US2020218279A1Robust Navigation of a Robotic VehicleQUALCOMM INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jiangtao Ren files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →